09:12 AM EST, 11/06/2025 (MT Newswires) -- Enovis ( ENOV ) reported fiscal Q3 adjusted earnings Thursday of $0.75 per diluted share, up from $0.73 a year earlier.

Analysts polled by FactSet expected $0.65.

Net sales for the quarter ended Oct. 3 were $548.9 million, up from $505.2 million a year earlier.

Analysts surveyed by FactSet expected $538.6 million.

For fiscal 2025, the medical technology firm now expects adjusted EPS of $3.10 to $3.25, from previous guidance of $3.05 to $3.20. Analysts polled by FactSet expect $3.13.

Revenue for the fiscal year is now expected between $2.24 billion and $2.27 billion, compared with its previous estimate of $2.25 billion and $2.28 billion. Analysts surveyed by FactSet expect $2.25 billion.